Fungal infection in solid organ recipients

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue SUPPL.2, 2012, Pages 49-56

  Fortún, Jesús ^a   Ruiz, Isabel ^b   Martín Dávila, Pilar ^a   Cuenca Estrella, Manuel ^c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Fungal infection; Solid organ recipients; Transplant

Indexed keywords

AMPHOTERICIN B; CALCINEURIN INHIBITOR; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; POLYENE; PYRROLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BLOOD CULTURE; CANDIDA; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; FILAMENTOUS ALGA; GRAFT RECIPIENT; HUMAN; IMMUNE DEFICIENCY; MIXED INFECTION; MORTALITY; MYCOSIS; NONHUMAN; SCEDOSPORIUM APIOSPERMUM; SURGERY; VIRUS INFECTION;

HUMANS; MYCOSES; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 84860486829     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(12)70082-4     Document Type: Article

References (62)

1. S. Gabardi, D.W. Kubiak, A.K. Chandraker, and S.G. Tullius Invasive fungal infections and antifungal therapies in solid organ transplant recipients Transpl Int 20 2007 993 1015
2. R.S. Garrido, J.M. Aguado, C. Díaz-Pedroche, O. Len, M. Montejo, and A. Moreno A review of critical periods for opportunistic infection in the new transplantation era Transplantation 82 2006 1457 1462
3. P.G. Pappas, B.D. Alexander, D.R. Andes, S. Hadley, C.A. Kauffman, and A. Freifeld Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin Infect Dis 50 2010 1101 1111
4. A.P. Limaye, P.A. Connolly, M. Sagar, T.R. Fritsche, B.T. Cookson, and L.J. Wheat Transmission of Histoplasma capsulatum by organ transplantation N Engl J Med 343 2000 1163 1166
5. J. Gavaldà, O. Len, R. San Juan, J.M. Aguado, J. Fortún, and C. Lumbreras Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study Clin Infect Dis 41 2005 52 59
6. J. Fortún, P. Martín-Dávila, S. Moreno, E. De Vicente, J. Nuño, and A. Candelas Risk factors for invasive aspergillosis in liver transplant recipients Liver Transpl 8 2002 1065 1070
7. N. Singh, A.P. Limaye, G. Forrest, N. Safdar, P. Muñoz, and K. Pursell Late-onset invasive aspergillosis in organ transplant recipients in the current era Med Mycol 44 2006 445 449
8. F.P. Silveira, E.J. Kwak, D.L. Paterson, J.M. Pilewski, K.R. McCurry, and S. Husain Posttransplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients J Heart Lung Transplant 27 2008 850 855
9. Anonymous Fungal infections Am J Transp 4 Suppl 10 2004 110 134
10. N. Singh, O. Lortholary, B.D. Alexander, K.L. Gupta, G.T. John, and K.J. Pursell Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection Transplantation 80 2005 1033
11. N. Singh, B.D. Alexander, O. Lortholary, F. Dromer, K.L. Gupta, G.T. John Cryptococcal Collaborative Transplant Study Group Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality J Infect Dis 195 2007 756 764
12. D.P. Kontoyiannis, R.E. Lewis, B.D. Alexander, O. Lortholary, F. Dromer, and K.L. Gupta Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis Antimicrob Agents Chemother 52 2008 735 738
13. N. Singh, B.D. Alexander, O. Lortholary, F. Dromer, K.L. Gupta, and G.T. John Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen Clin Infect Dis 46 2008 e12 e18
14. M. Cuenca-Estrella, L. Bernal-Martínez, G. Isla, A. Gómez-López, L. Alcázar-Fuoli, and M.J. Buitrago Incidence of zygomycosis in transplant recipients Clin Microbiol Infect 5 2009 37 40
15. D. Neofytos, J.A. Fishman, D. Horn, E. Anaissie, C.H. Chang, and A. Olyaei Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients Transpl Infect Dis 12 2010 220 229
16. N. Singh, J.M. Aguado, H. Bonatti, G. Forrest, K.L. Gupta, and N. Safdar Zygomycosis in solid organ transplant recipients: A prospective, matched case-control study to assess risks for disease and outcome J Infect Dis 200 2009 1002 1011
17. N.G. Almyroudis, D.A. Sutton, P. Linden, M.G. Rinaldi, J. Fung, and S. Kusne Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature Am J Transplant 6 2006 2365 2374
18. H.Y. Sun, G. Forrest, K.L. Gupta, J.M. Aguado, O. Lortholary, and M.B. Julia Rhinoorbital-cerebral zygomycosis in solid organ transplant recipients Transplantation 90 2010 85 92
19. A. Solé, and M. Salavert Fungal infections after lung transplantation Curr Opin Pulm Med 15 2009 243 253
20. B. Sendid, D. Caillot, B. Baccouch-Humbert, L. Klingspor, M. Grandjean, and A. Bonnin Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults J Clin Microbiol 41 2003 4551 4558
21. M. Mikulski, T. Calandra, M. Sanguinetti, D. Poulain, C. Viscoli Third European Conference on Infections in Leukemia Group The use of mannan antigen and antimannan antibodies in the diagnosis of invasive candidiasis: Recommendations from the Third European Conference on Infections in Leukemia Crit Care 14 2010 R222
22. L. Ostrosky-Zeichner, B.D. Alexander, D.H. Kett, J. Vazquez, P.G. Pappas, and F. Saeki Multicenter clinical evaluation of the (1 - >3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans Clin Infect Dis 41 2005 654 659
23. M.A. Mennink-Kersten, D. Ruegebrink, and P.E. Verweij Pseudomonas aeruginosa as a cause of 1,3-beta-d-glucan assay reactivity Clin Infect Dis 46 2008 1930 1931
24. S. Koo, J.M. Bryar, J.H. Page, L.R. Baden, and F.M. Marty Diagnostic performance of the (1 - >3)-beta-D-glucan assay for invasive fungal disease Clin Infect Dis 49 2009 1650 1659
25. T. Avni, L. Leibovici, and M. Paul PCR diagnosis of invasive candidiasis: Systematic review and meta-analysis J Clin Microbiol 49 2011 665 670
26. S. Ascioglu, J.H. Rex, B. De Pauw, J.E. Bennett, J. Bille, and F. Crokaert Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus Clin Infect Dis 34 2002 7 14
27. B. De Pauw, T.J. Walsh, J.P. Donnelly, D.A. Stevens, J.E. Edwards, and T. Calandra Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 2008 1813 1821
28. C.D. Pfeiffer, J.P. Fine, and N. Safdar Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis Clin Infect Dis 42 2006 1417 1427
29. J. Fortún, P. Martín-Dávila, M.E. Álvarez, A. Sánchez-Sousa, C. Quereda, E. Navas Ramon y Cajal Hospital's Liver Transplant Group Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients Transplantation 71 2001 145 149
30. A. Aubry, R. Porcher, J. Bottero, S. Touratier, T. Leblanc, and B. Brethon Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders J Clin Microbiol 44 2006 389 394
31. J. Fortún, P. Martín-Dávila, M.E. Álvarez, F. Norman, A. Sánchez-Sousa, and L. Gajate False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients Transplantation 87 2009 256 260
32. S. Husain, D.L. Paterson, S.M. Studer, M. Crespo, J. Pilewski, and M. Durkin Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients Transplantation 83 2007 1330 1336
33. C.J. Clancy, R.A. Jaber, H.L. Leather, J.R. Wingard, B. Staley, and L.J. Wheat Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients J Clin Microbiol 45 2007 1759 1765
34. M. Cuenca-Estrella, Y. Meije, C. Díaz-Pedroche, A. Gómez-López, M.J. Buitrago, and L. Bernal-Martínez Value of serial determinations of fungal DNA by a real-time PCRbased technique for early detection of invasive aspergillosis in patients with febrile neutropenia J Clin Microbiol 47 2009 379 384
35. F. Botterel, C. Farrugia, P. Ichai, J.M. Costa, F. Saliba, and S. Bretagne Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients Liver Transpl 14 2008 1678 1679
36. P.G. Pappas, C.A. Kauffman, D. Andes, D.K. Benjamin, T. Calandra, and J.E. Edwards Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America Clin Infect Dis 48 2009 503 535
37. J.M. Aguado, I. Ruiz-Camps, P. Muñoz, J. Mensa, B. Almirante, L. Vázquez Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED) Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update Enferm Infecc Microbiol Clin 29 2011 345 361
38. C.Y. Liu, L.J. Huang, W.S. Wang, T.L. Chen, C.C. Yen, and M.H. Yang Candidemia in cancer patients: Impact of early removal of non-tunneled central venous catheters on outcome J Infect 58 2009 154 160
39. N. De Wet, A. Llanos-Cuentas, J. Suleiman, E. Baraldi, E.F. Krantz, and M. Della Negra A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIVpositive patients Clin Infect Dis 39 2004 842 849
40. D.S. Krause, A.E. Simjee, C. Van Rensburg, J. Viljoen, T.J. Walsh, and B.P. Goldstein A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis Clin Infect Dis 39 2004 770 775
41. A. Villanueva, E.G. Arathoon, E. Gotuzzo, R.S. Berman, M.J. DiNubile, and C.A. Sable A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis Clin Infect Dis 33 2001 1529 1535
42. J.R. Perfect, W.E. Dismukes, F. Dromer, D.L. Goldman, J.R. Graybill, and R.J. Hamill Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america Clin Infect Dis 50 2010 291 322
43. N. Singh, O. Lortholary, B.D. Alexander, K.L. Gupta, G.T. John, and K. Pursell An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients Clin Infect Dis 40 2005 1756 1761
44. D.W. Denning, P. Ribaud, N. Milpied, D. Caillot, R. Herbrecht, and E. Thiel Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis Clin Infect Dis 34 2002 563 571
45. R. Herbrecht, D.W. Denning, T.F. Patterson, J.E. Bennett, R.E. Greene, and J.W. Oestmann Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 2002 408 415
46. J. Fortún, P. Martín-Dávila, M.A. Sánchez, V. Pintado, M.E. Álvarez, and A. Sánchez-Sousa Voriconazole in the treatment of invasive mold infections in transplant recipients Eur J Clin Microbiol Infect Dis 22 2003 408 413
47. M. Kleinberg Aspergillosis in the CLEAR outcomes trial: Working toward a realworld clinical perspective Med Mycol 43 2005 S289 S294
48. J. Groetzner, I. Kaczmarek, T. Wittwer, J. Strauch, B. Meiser, and T. Wahlers Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation J Heart Lung Transplant 27 2008 1 6
49. J. Maertens, G. Egerer, W.S. Shin, D. Reichert, M. Stek, and S. Chandwani Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: Results of a prospective observational registry BMC Infect Dis 10 2010 182
50. M. Winkler, J. Pratschke, U. Schulz, S. Zheng, M. Zhang, and W. Li Caspofungin for post solid organ transplant invasive fungal disease: Results of a retrospective observational study Transpl Infect Dis 12 2010 230 237
51. N. Singh, A.P. Limaye, G. Forrest, N. Safdar, P. Muñoz, and K. Pursell Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study Transplantation 81 2006 320 326
52. D.W. Denning, K.A. Marr, W.M. Lau, D.P. Facklam, V. Ratanatharathorn, and C. Becker Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis J Infect 53 2006 337 349
53. B.D. Alexander, J.R. Perfect, J.S. Daly, A. Restrepo, A.M. Tobón, and H. Patino Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant Transplantation 86 2008 791 796
54. H. Leather, R.M. Boyette, L. Tian, and J.R. Wingard Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients Biol Blood Marrow Transplant 12 2006 325 334
55. A.H. Saad, D.D. DePestel, and P.L. Carver Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants Pharmacotherapy 26 2006 1730 1744
56. R.N. Greenberg, K. Mullane, J.A. Van Burik, I. Raad, M.J. Abzuq, and G. Anstead Posaconazole as salvage therapy for zygomycosis Antimicrob Agents Chemother 50 2006 126 133
57. C. Reed, A. Ibrahim, J.E. Edwards Jr., I. Walot, and B. Spellberg Deferasirox, an ironchelating agent, as salvage therapy for rhinocerebral mucormycosis Antimicrob Agents Chemother 50 2006 3968 3969
58. C. Reed, R. Bryant, A.S. Ibrahim, J. Edwards Jr., S.G. Filler, and R. Goldberg Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis Clin Infect Dis 47 2008 364 371
59. F. Barchiesi, E. Spreghini, A. Santinelli, A.W. Fothergill, E. Pisa, and D. Giannini Posaconazole prophylaxis in experimental systemic zygomycosis Antimicrob Agents Chemother 51 2007 73 77
60. P. Troke, K. Aguirrebengoa, C. Arteaga, D. Ellis, C.H. Heath, and I. Lutsar Treatment of scedosporiosis with voriconazole: Clinical experience with 107 patients Antimicrob Agents Chemother 52 2008 1743 1750
61. J.L. Rodríguez-Tudela, J. Berenguer, J. Guarro, A.S. Kantarcioglu, R. Horre, and G.S. de Hoog Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases Med Mycol 47 2009 359 370
62. B.P. Howden, M.A. Slavin, A.P. Schwarer, and A.M. Mijch Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine Eur J Clin Microbiol Infect Dis 22 2003 111 113